• Clinical Evidence

EndoTool Software for Tight Glucose Control for Critically Ill Patients

Setting: 874-bed regional academic medical center

Objective

This retrospective study evaluates the safety and efficacy of EndoTool software for tight glucose control in the ICU.

Setting

874-bed regional academic medical center.

Results

  • Incidence of hypoglycemia <=40 mg/dL was 0.13% of blood glucose readings, and incidence of hypoglycemia <=60 mg/dL was 0.97% of blood glucose readings.
  • Some blood glucose readings <=40 mg/dL and <=60 mg/dL were associated with late blood glucose determinations.
  • Mean blood glucose was 121 mg/dL (± 38).
  • Mean blood glucose after 4 hours of control was 118 mg/dL (± 38).
  • Time to control <150 mg/dL was 2.7, 3.4, 4.5 and 5.0 hours for starting ranges of 151-200, 201-250, 251-300 and >300 mg/dL, respectively.
  • Critical care staff were supportive of EndoTool software for patient care and recommended it over previous paper protocols; they were instrumental in promoting it throughout the hospital.
  • Physician calls were basically eliminated.
  • Work and stress associated with tight glucose control was subjectively reduced.
  • Medical record documentation of care was simplified and improved. Quality assurance was convenient and easy.

Conclusions

Use of EndoTool software is shown to be both safe and effective, with very low incidence of hypoglycemia, and is recommended by critical care staff over paper protocols for tight glycemic control in the ICU.
Objective

This retrospective study evaluates the safety and efficacy of EndoTool software for tight glucose control in the ICU.

Setting

874-bed regional academic medical center.

Results
  • Incidence of hypoglycemia <=40 mg/dL was 0.13% of blood glucose readings, and incidence of hypoglycemia <=60 mg/dL was 0.97% of blood glucose readings.
  • Some blood glucose readings <=40 mg/dL and <=60 mg/dL were associated with late blood glucose determinations.
  • Mean blood glucose was 121 mg/dL (± 38).
  • Mean blood glucose after 4 hours of control was 118 mg/dL (± 38).
  • Time to control <150 mg/dL was 2.7, 3.4, 4.5 and 5.0 hours for starting ranges of 151-200, 201-250, 251-300 and >300 mg/dL, respectively.
  • Critical care staff were supportive of EndoTool software for patient care and recommended it over previous paper protocols; they were instrumental in promoting it throughout the hospital.
  • Physician calls were basically eliminated.
  • Work and stress associated with tight glucose control was subjectively reduced.
  • Medical record documentation of care was simplified and improved. Quality assurance was convenient and easy.
Conclusions

Use of EndoTool software is shown to be both safe and effective, with very low incidence of hypoglycemia, and is recommended by critical care staff over paper protocols for tight glycemic control in the ICU.

References

Authors

Steven Cochran, MD; Edith Miller, MD; Kelli Dunn, MD; William Burgess, MD; William Miles, MD; Kevin Lobdell, MD.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 34, Issue 12, pA68.

Year

2006

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective study evaluates the safety and efficacy of EndoTool software for tight glucose control in the ICU.

Setting

874-bed regional academic medical center.

Results
  • Incidence of hypoglycemia <=40 mg/dL was 0.13% of blood glucose readings, and incidence of hypoglycemia <=60 mg/dL was 0.97% of blood glucose readings.
  • Some blood glucose readings <=40 mg/dL and <=60 mg/dL were associated with late blood glucose determinations.
  • Mean blood glucose was 121 mg/dL (± 38).
  • Mean blood glucose after 4 hours of control was 118 mg/dL (± 38).
  • Time to control <150 mg/dL was 2.7, 3.4, 4.5 and 5.0 hours for starting ranges of 151-200, 201-250, 251-300 and >300 mg/dL, respectively.
  • Critical care staff were supportive of EndoTool software for patient care and recommended it over previous paper protocols; they were instrumental in promoting it throughout the hospital.
  • Physician calls were basically eliminated.
  • Work and stress associated with tight glucose control was subjectively reduced.
  • Medical record documentation of care was simplified and improved. Quality assurance was convenient and easy.
Conclusions

Use of EndoTool software is shown to be both safe and effective, with very low incidence of hypoglycemia, and is recommended by critical care staff over paper protocols for tight glycemic control in the ICU.

References

Authors

Steven Cochran, MD; Edith Miller, MD; Kelli Dunn, MD; William Burgess, MD; William Miles, MD; Kevin Lobdell, MD.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 34, Issue 12, pA68.

Year

2006

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

To evaluate the impact of EndoTool IV insulin dosing software on reducing severe hypoglycemia (SH) (blood glucose < 40 mg/dL) across 19-hospitals at a prominent health system, including outcomes in patients with renal insufficiency.
Image
  • Clinical Evidence

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

To evaluate the safety and efficacy of the EndoTool SubQ (ETSQ) insulin dosing application for subcutaneous (SQ) insulin administration in hospitalized patients, and to compare clinical outcomes against those treated using a standard insulin order set. The analysis also examined performance in high-risk patients with advanced renal impairment.
Image
  • Clinical Evidence

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
By submitting this form, you consent to the processing of your personal information, including sensitive personal information you provide, in accordance with the Monarch Medical Technologies Privacy Notice.